Pharmaceutical Powders for Respiratory Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 1604
Special Issue Editor
Interests: spray (freeze) drying technology; particle science and engineering; respiratory drug delivery
Special Issue Information
Dear Colleagues,
Dry powder for respiratory drug delivery has attracted extensive attention in the field of innovative pharmaceutical product design. However, pulmonary and intranasal delivery of biologics, i.e., vaccines, therapeutic peptides and proteins, and high-dose active pharmaceutical ingredients, i.e., antibiotics, antibacterial and antiviral drugs, are still challenging. To tackle such problems, innovative strategies of formulation design, pharmaceutical process and engineering, as well as powder characterization methods, are urgently required. Moreover, investigation of the structure regulation and pulmonary/intranasal delivery performance of inhalable dry powder should be involved.
This Special Issue aims to highlight recent advances in the fabrication and characterization methods of pharmaceutical powders for respiratory drug delivery.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Quality-by-Design (QbD) strategies;
- Innovative pharmaceutical process and engineering;
- Advanced powder characterization method;
- High-dose respiratory drug delivery;
- Inhaled nanomedicines;
- Inhaled vaccines of dry powder.
We look forward to receiving your contributions.
Prof. Dr. Winston Duo Wu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inhalable dry powder
- high-dose formulation
- pharmaceuticals process
- powder technology
- powder characterization
- scale-up strategies
- controlled release
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
